Synonyms: BRX-220 | BRX220 | Miplyffa®
arimoclomol is an approved drug (FDA (2024))
Compound class:
Synthetic organic
Comment: Arimoclomol is an oral therapeutic candidate for the treatment of amyotrophic lateral sclerosis (ALS). Arimoclomol may be delivered as the citrate salt (BRX-345 with PubChem CID 72710735)
|
|
Bioactivity Comments |
The precise primary molecular target(s), and the full mechanism of action of this compound are not fully resolved. |